QTTB Stock Analysis: Buy, Sell, or Hold?
QTTB - Q32 Bio Inc. Common Stock
$6.11
-0.31 (-4.83%)
▼
5d:
-15.72%
30d:
+24.95%
90d:
+90.94%
WAIT
LOW Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When QTTB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: QTTB is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: QTTB is down 15.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: QTTB is currently trading at $6.11, which is considered fair relative to its 30-day fair value range of $4.87 to $6.88.
Technical Outlook: Technically, QTTB is in a strong uptrend. Immediate support is located at $5.51, while resistance sits at $8.04. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.33 (+134.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, QTTB is in a strong uptrend. Immediate support is located at $5.51, while resistance sits at $8.04. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $14.33 (+134.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$4.87 -
$6.88
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 134.6% below Wall St target ($14.33)
- WARNING: Recommendation downgraded due to -15.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.87 -
$6.88
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.51
Resistance Level
$8.05
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.80
Wall Street Target
$14.33
(+134.6%)
Profit Margin
55.5%
Share & Embed Analysis
Last updated: April 02, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QTTB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Jodie Pope Morrison
SELL
9896 shares
2026-02-25
Lee Kalowski
SELL
3995 shares
2026-02-25
Shelia M Violette
SELL
2815 shares
2026-02-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 66 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 52 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 62 BUY |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 61 BUY |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$109 | 48 HOLD |
